Vivos (VVOS) news
Recent news
Vivos Therapeutics - Center expected to begin treating patients and generating revenue in Q1 22027
AInvest Wire · 3d agoVivos Therapeutics - Expects to hold 75% majority interest in AIM Florida
Vivos Therapeutics Inc. (NASDAQ: VIVOS) has announced its intention to acquire a 75% majority interest in AIM Florida, a provider of dental sleep medicine services. The transaction, if finalized, would expand Vivos’ presence in the dental sleep medicine market and align with its strategic focus on…
AInvest Wire · 3d agoVivos Therapeutics Q2 gross profit USD 2.953 million
AInvest Wire · Aug 14, 2026Vivos Therapeutics expands Greenway Health partnership to deploy AI-enabled platform across all clinical and revenue operations
AInvest Wire · Aug 11, 2026Vivos Therapeutics announces issuance of new US patent broadening protection for its Vivos Care oral medical device technology
Vivos Inc. has announced the issuance of U.S. Patent No. 12,521,452 B2 by the United States Patent and Trademark Office (USPTO), titled “Radiotherapy Gel and Method” . This development strengthens the company’s intellectual property portfolio and expands its patent protection for its Precision…
AInvest Wire · Aug 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.